Advertisement

Topics

Search Results for "Blue Oval Pill With 68 Taro"

07:42 EST 14th February 2016 | BioPortfolio

Matching Channels

Blue hues

Von Willebrand's Disease

von Willebrand disease (vWD) is the most common hereditary coagulation abnormality described in humans, although it can also be acquired as a result of other medical conditions. It arises from a qua...

Matching News

Taro to Announce Third Quarter Results on February 10, 2016

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2015, after the c...

Taro to Announce First Quarter Results on August 6, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and three months ended June 30, 2015, after the clos...

CORRECTING and REPLACING Taro to Announce Third Quarter Results on February 10, 2016

The date at the end of the first paragraph of release dated February 2, 2016 should read: Wednesday, February 10, 2016 (instead of Tuesday, February 10, 2016). Th...

Looks Can be Deceiving—Protectable Elements of a Pill’s Appearance

Marc P. Misthal | Gottlieb, Rackman & Reisman Everyone has heard of Pfizer’s Viagra. Most people know that it is a “little blue pill”, even if they have not used it themselves....

Taro Pharmaceutical Industries' (TARO) CEO Kal Sundaram on Q2 2015 Results - Earnings Call Transcript

FDA approves Taro’s Keveyis for hyperkalemic paralysis

The US Food and Drug Administration has approved Taro Pharmaceutical Industries’ Keveyis (dichlorphenamide)…

Taro to Announce Second Quarter Results on November 3, 2015

Earnings Call to Discuss Results to be Conducted Wednesday, November 4 at 8:00 am ET Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to r...

Taro’s Keveyis gets FDA approval

David SalazarIn order to ensure that patients receive treatment for periodic paralysis, Taro will be partnering with Diplomat Pharmacy, where patients and caregivers will receive treatment access and ...

Matching PubMed Articles

Red pill, blue pill: reflections on the emerging large vessel stroke 'market'.

Cost-Benefit Analysis of Managing the Papuana uninodis (Coleoptera: Scarabaeidae) Taro Beetle in Fiji.

Taro (Colocasia esculenta (L.) Schott) plays a prominent role in the economies and cultures of Pacific Island countries such as Fiji. Unfortunately, taro is highly susceptible to invasion from taro be...

Bioethanol production from taro waste using thermo-tolerant yeast Kluyveromyces marxianus K21.

In the present study, evaluation and optimization of taro waste (TW), which was mainly composed of taro peels that contain many starch residues, as the main carbon source in medium were studied. The f...

Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in High fructose-fed rats.

Simiao pill is one of the most frequently prescriptions in traditional Chinese medicine to treat hyperuricemia and gout. This study was to investigate the protective effects of Simiao pill on renal gl...

Characterization by Small RNA Sequencing of Taro Bacilliform CH Virus (TaBCHV), a Novel Badnavirus.

RNA silencing is an antiviral immunity that regulates gene expression through the production of small RNAs (sRNAs). In this study, deep sequencing of small RNAs was used to identify viruses infecting ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement